Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 11-2021 | 09-2021 | 08-2021 | |
| Operating Expenses | 1,946 | 0 | 2,552 | 2,245 | 0 |
| Operating Income | -1,946 | N/A | -2,552 | -2,245 | N/A |
| Interest Expense | 0 | 0 | 1 | 0 | 0 |
| Other Income | -19 | 0 | 3 | 0 | 0 |
| Pre-tax Income | -1,965 | 0 | -2,550 | -2,245 | 0 |
| Net Income Continuous | -1,965 | N/A | -2,550 | -2,245 | N/A |
| Net Income | $-1,965 | $N/A | $-2,550 | $-2,245 | $N/A |
| EPS Basic Total Ops | -0.70 | N/A | -1.20 | -1.37 | N/A |
| EPS Basic Continuous Ops | -0.70 | N/A | -1.26 | -1.37 | N/A |
| EPS Diluted Total Ops | -0.70 | N/A | -1.20 | -1.37 | N/A |
| EPS Diluted Continuous Ops | -0.70 | N/A | -1.26 | -1.37 | N/A |
| EBITDA(a) | $-1,946 | $N/A | $-2,552 | $-2,245 | $N/A |